Felipe Garcia Alcaide is a Senior Consultant of the Infectious Diseases & AIDS unit at the Hospital Clinic of Barcelona, Associate Professor of Medicine at the University of Barcelona and Coordinator in Spain of HIV-1 vaccine research group of the Spanish AIDS Research Network. He has been Principal Investigator of more than 30 clinical trials with preventive or therapeutic vaccines or immune based therapies during the last 20 years. He has the support of a team of experts in clinical trials using immune based therapies and statisticians. He was the WP Leader of the European project MUNANOVAC and iNANODC and he is the Consortium Coordinator of the FP7 project iHIVARNA (Therapeutic TriMix/mRNA based Vaccine in Chronic HIV-1 Infected Patients on Antiretroviral Therapy). Felipe Garcia Alcaide is a Senior Consultant of the Infectious Diseases & AIDS unit at the Hospital Clinic of Barcelona, Associate Professor of Medicine at the University of Barcelona and Coordinator in Spain of HIV-1 vaccine research group of the Spanish AIDS Research Network. He has been Principal Investigator of more than 30 clinical trials with preventive or therapeutic vaccines or immune based therapies during the last 20 years. He has the support of a team of experts in clinical trials using immune based therapies and statisticians. He was the WP Leader of the European project MUNANOVAC and iNANODC and he is the Consortium Coordinator of the FP7 project iHIVARNA (Therapeutic TriMix/mRNA based Vaccine in Chronic HIV-1 Infected Patients on Antiretroviral Therapy).

Vaccines & Vaccination